REMEDi4ALL is an EU-funded research initiative to drive forward the repurposing of medicines in Europe. The platform has the potential to bring down times and costs of drug development by focusing on already approved, discontinued, shelved or investigational therapeutics.
The REMEDi4ALL consortium brings together a unique combination of expertise to address the complexities of drug repurposing. Under the leadership of EATRIS, the European infrastructure for translational medicine, 24 organisations in the fields of clinical and translational research, clinical operations, patient engagement and education, regulatory framework, funding, governance, Health Technology Assessment (HTA) and pricing and reimbursement will closely collaborate to make drug repurposing mainstream.
In REMEDi4ALL, ZonMw has the lead in creating a funders network and ‘think tank’ with the aim to discuss policy issues, share best funding practices, co-ordinate (new) funding streams, promote joint calls and develop innovative co-funding models for drug repurposing. ZonMw will also contribute to improving the market access and policy environment for drug repurposing.
Calling all research funders willing to advance drug repurposing: we would love to hear your experiences & ideas within the International Drug Repurposing Funders Network.